Quantcast
Last updated on April 17, 2014 at 7:39 EDT

Latest Anti-diabetic drug Stories

2012-05-23 06:25:31

FORT WASHINGTON, Pa., May 23, 2012 /PRNewswire/ -- Nutrisystem (NASDAQ: NTRI), a leading provider of weight management products and services, today announced that it has been named a National Strategic Partner of the American Diabetes Association in recognition of its commitment to support the mission and the Association's movement to Stop Diabetes®. Nutrisystem offers the Nutrisystem® D® program, the leading home-delivered weight loss program clinically tested, in combination...

2012-05-23 02:24:50

PHILADELPHIA, May 23, 2012 /PRNewswire/ -- The Blood Sugar Basics Game Plan, developed by the American College of Endocrinology (ACE), with support from Merck (NYSE:MRK) (known as MSD outside the United States and Canada), is kicking off to help the nearly 26 million people in the U.S. who have diabetes find new ways to help manage their disease. The interactive, user-friendly program breaks down diabetes management into four easy-to-understand "goals" to help people with type 2 diabetes take...

2012-05-21 23:01:02

The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.sideeffectsrx.com, is a team of professional consumer advocates whose mission is alerting the public to the potential problems with using certain prescription medications. They do so by providing free online educational resources that provide insight into potential issues that could arise. The CJF hereby alerts the public to a ruling made in the ongoing Actos Multi-District Litigation Side...

2012-04-25 18:20:14

DEERFIELD, Ill. and OSAKA, Japan, April 25, 2012 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc. today announced that the company received a complete response letter from the United States (U.S.) Food and Drug Administration (FDA) regarding New Drug Applications (NDAs) for alogliptin and fixed-dose combination (FDC) alogliptin and pioglitazone. Recently, Takeda provided...

2012-04-23 23:00:34

The Consumer Justice Foundation, a for-profit corporation whose Web site URL can be found at http://www.sideeffectsrx.com, is a team of professional consumer advocates who provide free informational online resources regarding the potential dangers of certain prescription medications. The CJF hereby alerts the public that Health Canada has issued a statement linking the use of Actos to an increased risk of bladder cancer and that the labeling on the packages of this drug will include a warning...

2012-03-21 02:22:33

SAN DIEGO, March 21, 2012 /PRNewswire/ -- Profil(®) Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today its continued focus on contributing to scientific research in the public domain. The company published research on new therapies in diabetes in nine scientific journals last year and one of its key scientists Prof. Andrew Krentz has authored two textbooks on drug therapy for type 2 diabetes, due to...

2012-03-19 23:01:05

The Consumer Justice Foundation, a for-profit corporation whose web site URL can be found at http://www.sideeffectsrx.com is staffed by a team of professional consumer advocates whose mission is to alert the public of the potential dangers of certain prescription drugs by way of free online information resources. The CJF hereby alerts the public of an Actos whistleblower lawsuit that alleges that Takeda Pharmaceuticals, the manufacturer of diabetes drub Actos, influenced reports of risks of...

2012-03-12 10:49:00

SAN FRANCISCO, March 12, 2012 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) is developing novel insulin sensitizers that exert their pharmacological effects through an as yet undisclosed mitochondrial molecular target. This breakthrough understanding has significant implications for the discovery of new drugs to treat type 2 diabetes and will be previewed during the Phacilitate meeting Metabolic Leaders Forum 2012 in San Francisco, March 12 - 14, 2012. MSDC compounds...

2012-02-28 14:00:00

CRESSKILL, N.J., Feb. 28, 2012 /PRNewswire/ -- In January 2012, GlaxoSmithKline ("GSK") the United Kingdom's largest pharmaceutical company agreed to resolve more than 20,000 cases alleging their diabetes drug Avandia causes heart attacks. Meanwhile, the plaintiffs' attorneys have not been compensated for their out-of-pocket expenses incurred in pursuing these meritorious cases. RD Legal Funding, LLC ("RD Legal") a leading lawsuit settlement funding company, is available to provide qualified...

2012-02-15 08:00:00

The US Drug Watchdog says, "We need the help of family members, and loved ones of diabetics who now have bladder cancer to ask the diabetic if they were using the diabetes drug called Actos, prior to being diagnosed with bladders cancer. Not many diabetics, who now have bladder cancer would ever consider a diabetes drug could be the culprit for their bladder cancer, but we fear this is exactly what could have happened. We want to get every possible victim identified to insure they have the...